… controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk
… Among RCTs, there was a nonstatistically significant reduction in CHD risk with EPA+DHA … significant CHD risk reduction with EPA+DHA provision among higher-risk populations, …..... Read More